Αρχική World News 2020 Cancer Incidence and Mortality in EU-27 Countries

2020 Cancer Incidence and Mortality in EU-27 Countries

On 22 July 2020, the Joint Research Centre (JRC) of the European Commission released the 2020 estimates on the burden of cancer in the European Union (EU). Female breast cancer is still estimated to be the most commonly diagnosed cancer.

The cancer burden is estimated to have risen to 2.7 million new cases (all types, excluding non-melanoma skin cancer) and 1.3 million deaths in 2020.

These estimates reveal that cancer affects men slightly more than women, with 54% of new cases and 56% of deaths.

As is well known, cancer mostly affects older adults. The 2020 estimates reveal that 62% of estimated new diagnoses and 76% of estimated deaths occur in people over 65 years old.

What are the most common cancers diagnosed and what cancers cause most deaths?

Female breast cancer is the most commonly diagnosed cancer. Over 355,000 women in the EU-27 are estimated to be diagnosed with breast cancer in 2020 (13.3% of all cancer diagnoses). This is followed by colorectal (341,000, 12.7%), prostate (336,000, 12.5%) and lung cancer (318,000, 11.9%).

The most common causes of death are from cancers of the lung (20.4% of all cancer deaths), followed by colorectal (12.4%), female breast (7.3%) and pancreatic cancer (7.1%). 

Higher incidence rates are estimated in the Nordic countries.

However, mortality rates for all cancers combined are estimated to be higher in Eastern countries, for both men and women. 

These 2020 estimates are the outcome of a collaborative project within the JRC and the European Network of Cancer Registries, together with the International Agency for Research on Cancer (IARC). They will be included in the forthcoming update of IARC’s GLOBOCAN project later this year.

More on measuring cancer burden and its time trends across Europe from the European Cancer Information System you can find here.

How is the COVID-19 pandemic affecting the burden of cancer?

This is not clear yet, especially considering the geographical variations and irregular evolution of the pandemic across countries.

However, there have been reported delays in cancer screening and diagnoses. Yet in some countries, there have been reports that cancer diagnoses have picked up after the lockdown ended.

Unfortunately, the effects of this pandemic are not reflected in these 2020 estimates because they are based on incidence trends from past years.

Therefore, the JRC reported that they might even observe a possible overestimation of 2020 incidence rates in some countries. They will however be able to account for this bias through detailed analyses when such data become available.

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

An existing blood test for ovarian cancer has been re-evaluated. The results are in.

Ovarian cancer is the sixth most common cancer in women in the UK, with about 7,400 new cases every year. This number equates to...

How to Stay Healthy After Cancer

I try to pack helpful advice into every follow-up visit I have with patients, focusing on little tips that help foster healthy lifestyles. This...

Feasibility and Preliminary Efficacy Results of the Beat AML Study

Precision medicine in acute myeloid leukaemia (AML) is feasible in terms of providing cytogenetic and mutational data within 7 days, allowing their rapid incorporation into...

Woman Battles Breast Cancer While Pregnant, Delivers Healthy Baby Boy

When she was six months pregnant, Desiree Doughty noticed that something seemed to be wrong with her breasts. “I noticed that one of my breasts...

Pumpkin Season!

Halloween may look different this year but we can still decorate our homes and enjoy a favorite fall treat – pumpkin and pumpkin seeds....

ACHIEVE-2 Results of Oxaliplatin-Based Adjuvant Chemotherapy in Asian Patients with High-Risk Stage II Colon Cancer

The Asian researchers reported on 25 October 2020 in the Annals of Oncology that 3-month of combination therapy for adjuvant treatment of high-risk stage...